Pyxis Oncology, Inc. (PYXS)
NASDAQ·Healthcare·Biotechnology
$1.71
-3.13%
Mkt Cap $93.40M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$6.67
Range $5.00 – $8.00
Implied Upside
+291.2%
Consensus $6.67 vs current $1.71
NASDAQ·Healthcare·Biotechnology
$1.71
-3.13%
Mkt Cap $93.40M
No recent rating data.
Price Target (7 analysts)
$6.67
Range $5.00 – $8.00
+291.2%
Consensus $6.67 vs current $1.71